PERISCOPE and the effect of pioglitazone on the progression of coronary artery disease in patients with diabetes.
Marx
Nikolaus
N
Department of Internal Medicine II - Cardiology, University of Ulm, Robert-Koch-Str. 8, D-89081 Ulm, Germany. nikolaus.marx@uniklinik-ulm.de
D003324:Coronary Artery Disease / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000077205:Pioglitazone; D016032:Randomized Controlled Trials as Topic; D045162:Thiazolidinediones / Q000627:therapeutic use*; D016896:Treatment Outcome; D014463:Ultrasonography
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone